The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injectable Dermal Filler Market Research Report 2024
Synopsis
Injectable dermal fillers are gel-like substances injected under the skin to restore lost volume, smooth and soften wrinkles or enhance facial contours. Injectable dermal fillers have developed rapidly and are getting closer and closer to "perfect" products: long-lasting but non-permanent, high tolerance, delicate and natural cosmetic effects, and reversible in the event of adverse surgical outcomes.
The global Injectable Dermal Filler market was valued at US$ 3797 million in 2023 and is anticipated to reach US$ 8963.9 million by 2030, witnessing a CAGR of 12.9% during the forecast period 2024-2030.
Global Injectable Dermal Filler key players include Allergan, Galderma, LG Life Sciences, Merz, HUGEL, etc. Global top five manufacturers hold a share about 65%. Americas is the largest market, with a share about 40%, followed by APAC and Europe, both have a share about 56 percent. In terms of product, Hyaluronic Acid is the largest segment, with a share over 81%. And in terms of application, the largest application is Specialty & Dermatology Clinics, followed by Hospitals, etc.
This report aims to provide a comprehensive presentation of the global market for Injectable Dermal Filler, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Dermal Filler.
Report Scope
The Injectable Dermal Filler market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Dermal Filler market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Dermal Filler manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Galderma
LG Life Sciences
Merz
HUGEL
Beijing IMEIK
Medytox
Bloomage BioTechnology
Croma-Pharma GmbH
Cleviel (Pharma Research Products)
Elravie (Humedix)
Sinclair
Haohai Biological Technology
Q.O.Fill (JW Pharmaceutical)
Teoxane
Suneva Medical
Segment by Type
Hyaluronic Acid
Collagen
CaHA
Others
Segment by Application
Specialty & Dermatology Clinics
Hospitals
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Dermal Filler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Dermal Filler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Injectable dermal fillers are gel-like substances injected under the skin to restore lost volume, smooth and soften wrinkles or enhance facial contours. Injectable dermal fillers have developed rapidly and are getting closer and closer to "perfect" products: long-lasting but non-permanent, high tolerance, delicate and natural cosmetic effects, and reversible in the event of adverse surgical outcomes.
The global Injectable Dermal Filler market was valued at US$ 3797 million in 2023 and is anticipated to reach US$ 8963.9 million by 2030, witnessing a CAGR of 12.9% during the forecast period 2024-2030.
Global Injectable Dermal Filler key players include Allergan, Galderma, LG Life Sciences, Merz, HUGEL, etc. Global top five manufacturers hold a share about 65%. Americas is the largest market, with a share about 40%, followed by APAC and Europe, both have a share about 56 percent. In terms of product, Hyaluronic Acid is the largest segment, with a share over 81%. And in terms of application, the largest application is Specialty & Dermatology Clinics, followed by Hospitals, etc.
This report aims to provide a comprehensive presentation of the global market for Injectable Dermal Filler, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Dermal Filler.
Report Scope
The Injectable Dermal Filler market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Dermal Filler market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Dermal Filler manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Galderma
LG Life Sciences
Merz
HUGEL
Beijing IMEIK
Medytox
Bloomage BioTechnology
Croma-Pharma GmbH
Cleviel (Pharma Research Products)
Elravie (Humedix)
Sinclair
Haohai Biological Technology
Q.O.Fill (JW Pharmaceutical)
Teoxane
Suneva Medical
Segment by Type
Hyaluronic Acid
Collagen
CaHA
Others
Segment by Application
Specialty & Dermatology Clinics
Hospitals
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Dermal Filler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Dermal Filler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Injectable Dermal Filler Market Overview
1.1 Product Overview and Scope of Injectable Dermal Filler
1.2 Injectable Dermal Filler Segment by Type
1.2.1 Global Injectable Dermal Filler Market Value Comparison by Type (2024-2030)
1.2.2 Hyaluronic Acid
1.2.3 Collagen
1.2.4 CaHA
1.2.5 Others
1.3 Injectable Dermal Filler Segment by Application
1.3.1 Global Injectable Dermal Filler Market Value by Application: (2024-2030)
1.3.2 Specialty & Dermatology Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Global Injectable Dermal Filler Market Size Estimates and Forecasts
1.4.1 Global Injectable Dermal Filler Revenue 2019-2030
1.4.2 Global Injectable Dermal Filler Sales 2019-2030
1.4.3 Global Injectable Dermal Filler Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injectable Dermal Filler Market Competition by Manufacturers
2.1 Global Injectable Dermal Filler Sales Market Share by Manufacturers (2019-2024)
2.2 Global Injectable Dermal Filler Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Injectable Dermal Filler Average Price by Manufacturers (2019-2024)
2.4 Global Injectable Dermal Filler Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Dermal Filler, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Dermal Filler, Product Type & Application
2.7 Injectable Dermal Filler Market Competitive Situation and Trends
2.7.1 Injectable Dermal Filler Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injectable Dermal Filler Players Market Share by Revenue
2.7.3 Global Injectable Dermal Filler Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Dermal Filler Retrospective Market Scenario by Region
3.1 Global Injectable Dermal Filler Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injectable Dermal Filler Global Injectable Dermal Filler Sales by Region: 2019-2030
3.2.1 Global Injectable Dermal Filler Sales by Region: 2019-2024
3.2.2 Global Injectable Dermal Filler Sales by Region: 2025-2030
3.3 Global Injectable Dermal Filler Global Injectable Dermal Filler Revenue by Region: 2019-2030
3.3.1 Global Injectable Dermal Filler Revenue by Region: 2019-2024
3.3.2 Global Injectable Dermal Filler Revenue by Region: 2025-2030
3.4 North America Injectable Dermal Filler Market Facts & Figures by Country
3.4.1 North America Injectable Dermal Filler Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injectable Dermal Filler Sales by Country (2019-2030)
3.4.3 North America Injectable Dermal Filler Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable Dermal Filler Market Facts & Figures by Country
3.5.1 Europe Injectable Dermal Filler Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injectable Dermal Filler Sales by Country (2019-2030)
3.5.3 Europe Injectable Dermal Filler Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Dermal Filler Market Facts & Figures by Country
3.6.1 Asia Pacific Injectable Dermal Filler Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injectable Dermal Filler Sales by Country (2019-2030)
3.6.3 Asia Pacific Injectable Dermal Filler Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injectable Dermal Filler Market Facts & Figures by Country
3.7.1 Latin America Injectable Dermal Filler Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injectable Dermal Filler Sales by Country (2019-2030)
3.7.3 Latin America Injectable Dermal Filler Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Dermal Filler Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Dermal Filler Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injectable Dermal Filler Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injectable Dermal Filler Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Dermal Filler Sales by Type (2019-2030)
4.1.1 Global Injectable Dermal Filler Sales by Type (2019-2024)
4.1.2 Global Injectable Dermal Filler Sales by Type (2025-2030)
4.1.3 Global Injectable Dermal Filler Sales Market Share by Type (2019-2030)
4.2 Global Injectable Dermal Filler Revenue by Type (2019-2030)
4.2.1 Global Injectable Dermal Filler Revenue by Type (2019-2024)
4.2.2 Global Injectable Dermal Filler Revenue by Type (2025-2030)
4.2.3 Global Injectable Dermal Filler Revenue Market Share by Type (2019-2030)
4.3 Global Injectable Dermal Filler Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injectable Dermal Filler Sales by Application (2019-2030)
5.1.1 Global Injectable Dermal Filler Sales by Application (2019-2024)
5.1.2 Global Injectable Dermal Filler Sales by Application (2025-2030)
5.1.3 Global Injectable Dermal Filler Sales Market Share by Application (2019-2030)
5.2 Global Injectable Dermal Filler Revenue by Application (2019-2030)
5.2.1 Global Injectable Dermal Filler Revenue by Application (2019-2024)
5.2.2 Global Injectable Dermal Filler Revenue by Application (2025-2030)
5.2.3 Global Injectable Dermal Filler Revenue Market Share by Application (2019-2030)
5.3 Global Injectable Dermal Filler Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Injectable Dermal Filler Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Galderma
6.2.1 Galderma Corporation Information
6.2.2 Galderma Description and Business Overview
6.2.3 Galderma Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Galderma Injectable Dermal Filler Product Portfolio
6.2.5 Galderma Recent Developments/Updates
6.3 LG Life Sciences
6.3.1 LG Life Sciences Corporation Information
6.3.2 LG Life Sciences Description and Business Overview
6.3.3 LG Life Sciences Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.3.4 LG Life Sciences Injectable Dermal Filler Product Portfolio
6.3.5 LG Life Sciences Recent Developments/Updates
6.4 Merz
6.4.1 Merz Corporation Information
6.4.2 Merz Description and Business Overview
6.4.3 Merz Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merz Injectable Dermal Filler Product Portfolio
6.4.5 Merz Recent Developments/Updates
6.5 HUGEL
6.5.1 HUGEL Corporation Information
6.5.2 HUGEL Description and Business Overview
6.5.3 HUGEL Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.5.4 HUGEL Injectable Dermal Filler Product Portfolio
6.5.5 HUGEL Recent Developments/Updates
6.6 Beijing IMEIK
6.6.1 Beijing IMEIK Corporation Information
6.6.2 Beijing IMEIK Description and Business Overview
6.6.3 Beijing IMEIK Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Beijing IMEIK Injectable Dermal Filler Product Portfolio
6.6.5 Beijing IMEIK Recent Developments/Updates
6.7 Medytox
6.6.1 Medytox Corporation Information
6.6.2 Medytox Description and Business Overview
6.6.3 Medytox Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medytox Injectable Dermal Filler Product Portfolio
6.7.5 Medytox Recent Developments/Updates
6.8 Bloomage BioTechnology
6.8.1 Bloomage BioTechnology Corporation Information
6.8.2 Bloomage BioTechnology Description and Business Overview
6.8.3 Bloomage BioTechnology Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bloomage BioTechnology Injectable Dermal Filler Product Portfolio
6.8.5 Bloomage BioTechnology Recent Developments/Updates
6.9 Croma-Pharma GmbH
6.9.1 Croma-Pharma GmbH Corporation Information
6.9.2 Croma-Pharma GmbH Description and Business Overview
6.9.3 Croma-Pharma GmbH Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Croma-Pharma GmbH Injectable Dermal Filler Product Portfolio
6.9.5 Croma-Pharma GmbH Recent Developments/Updates
6.10 Cleviel (Pharma Research Products)
6.10.1 Cleviel (Pharma Research Products) Corporation Information
6.10.2 Cleviel (Pharma Research Products) Description and Business Overview
6.10.3 Cleviel (Pharma Research Products) Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cleviel (Pharma Research Products) Injectable Dermal Filler Product Portfolio
6.10.5 Cleviel (Pharma Research Products) Recent Developments/Updates
6.11 Elravie (Humedix)
6.11.1 Elravie (Humedix) Corporation Information
6.11.2 Elravie (Humedix) Injectable Dermal Filler Description and Business Overview
6.11.3 Elravie (Humedix) Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Elravie (Humedix) Injectable Dermal Filler Product Portfolio
6.11.5 Elravie (Humedix) Recent Developments/Updates
6.12 Sinclair
6.12.1 Sinclair Corporation Information
6.12.2 Sinclair Injectable Dermal Filler Description and Business Overview
6.12.3 Sinclair Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sinclair Injectable Dermal Filler Product Portfolio
6.12.5 Sinclair Recent Developments/Updates
6.13 Haohai Biological Technology
6.13.1 Haohai Biological Technology Corporation Information
6.13.2 Haohai Biological Technology Injectable Dermal Filler Description and Business Overview
6.13.3 Haohai Biological Technology Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Haohai Biological Technology Injectable Dermal Filler Product Portfolio
6.13.5 Haohai Biological Technology Recent Developments/Updates
6.14 Q.O.Fill (JW Pharmaceutical)
6.14.1 Q.O.Fill (JW Pharmaceutical) Corporation Information
6.14.2 Q.O.Fill (JW Pharmaceutical) Injectable Dermal Filler Description and Business Overview
6.14.3 Q.O.Fill (JW Pharmaceutical) Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Q.O.Fill (JW Pharmaceutical) Injectable Dermal Filler Product Portfolio
6.14.5 Q.O.Fill (JW Pharmaceutical) Recent Developments/Updates
6.15 Teoxane
6.15.1 Teoxane Corporation Information
6.15.2 Teoxane Injectable Dermal Filler Description and Business Overview
6.15.3 Teoxane Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Teoxane Injectable Dermal Filler Product Portfolio
6.15.5 Teoxane Recent Developments/Updates
6.16 Suneva Medical
6.16.1 Suneva Medical Corporation Information
6.16.2 Suneva Medical Injectable Dermal Filler Description and Business Overview
6.16.3 Suneva Medical Injectable Dermal Filler Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Suneva Medical Injectable Dermal Filler Product Portfolio
6.16.5 Suneva Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Dermal Filler Industry Chain Analysis
7.2 Injectable Dermal Filler Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Dermal Filler Production Mode & Process
7.4 Injectable Dermal Filler Sales and Marketing
7.4.1 Injectable Dermal Filler Sales Channels
7.4.2 Injectable Dermal Filler Distributors
7.5 Injectable Dermal Filler Customers
8 Injectable Dermal Filler Market Dynamics
8.1 Injectable Dermal Filler Industry Trends
8.2 Injectable Dermal Filler Market Drivers
8.3 Injectable Dermal Filler Market Challenges
8.4 Injectable Dermal Filler Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
